New York, NY -- (SBWIRE) -- 01/23/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Brocade Communications Systems, Inc.(NASDAQ:BRCD),ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC),Vical Incorporated(NASDAQ:VICL),JetBlue Airways Corporation(NASDAQ:JBLU)
Brocade Communications Systems, Inc.(NASDAQ:BRCD)’s reported the decrease of -0.31% to close at $9.52 with the overall traded volume of 6.12M shares. Its market capitalization on last close reached to $4.23B. Its intraday-low price was $9.48 and its hit its day's highest price at $9.60.
Brocade Communications Systems, Inc. (Brocade) is a supplier of networking equipment, including end-to-end Internet Protocol (IP)-based Ethernet networking solutions and storage area networking solutions for businesses and organizations of all types and sizes, including global enterprises,
Should BRCD a Buy or Sell Now? Find Out Here
ImmunoCellular Therapeutics Ltd(NYSEMKT:IMUC) decrease -9.74% settle at $1.39. Its total traded volume during last trading session was 6.04M shares. The overall market worth of this company is about $79.36M. The 52 week range of the stock remained $0.65 - $4.00, while its day's lowest price was $1.31 and its hit its day's highest price at $1.45.
ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
What IMUC Charts Are Signaling for Traders? Find Out Here
Vical Incorporated(NASDAQ:VICL)’s reported the increase of 3.61% to close at $1.72 with the overall traded volume of 5.91M shares. Its market capitalization on last close reached to $149.26 million. Its intraday-low price was $1.63 and its hit its day's highest price at $1.78.
Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Should VICL a Buy or Sell Now? Find Out Here
JetBlue Airways Corporation(NASDAQ:JBLU) increase 3.31% settle at $9.37. Its total traded volume during last trading session was 5.86M shares. The overall market worth of this company is about $2.63B. The 52 week range of the stock remained $5.70 - $9.45, while its day's lowest price was $9.07 and its hit its day's highest price at $9.45.
JetBlue Airways Corporation (JetBlue) is a passenger airline that operates primarily on point-to-point routes with its fleet of 120 Airbus A320 aircraft and 49 EMBRAER 190 aircraft.
What JBLU Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)